Presentation TCT 2013 The Ongoing Saga of Short DAPT Therapy After DES: Navigating Device Evolution, New Pharmacotherapy, and Changing Clinical Practice Standards Presenter: Roxana Mehran October 30, 2013
News Conference News TCT 2013 PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years October 30, 2013
News Conference News TCT 2013 Innovation in Intervention: Perspectives from Industry October 30, 2013
News Conference News TCT 2013 Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients October 30, 2013
News Industry News Abbott's MitraClip® Treatment Demonstrates Positive Results for Patients with Degenerative Mitral Regurgitation at Prohibitive Risk for Surgery October 30, 2013
Presentation TCT 2013 Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA Presenter: Miroslava Stolcova October 29, 2013
News Conference News TCT 2013 State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors October 29, 2013
News Industry News New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented Today at Scientific Symposium October 29, 2013
News Conference News TCT 2013 Memories of TCT from the Beginning: Martin B. Leon, MD October 29, 2013
News Industry News Clinical Trial Finds That Corevalve Reduces Rate of Death and Stroke in Sickest Patients with Aortic Stenosis October 29, 2013
News Conference News TCT 2013 BOSS: Sodium Bicarbonate May Protect Heart After Coronary Angiography October 29, 2013
News Industry News Philips and RealView Imaging conclude world’s first study to evaluate live 3D holographic imaging in interventional cardiology October 28, 2013
News Conference News TCT 2013 Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance October 28, 2013
News Industry News Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013 October 28, 2013
News Conference News TCT 2013 Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients October 28, 2013